この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2011/6/81 分で読めます
Generic Drug User Fee; Notice of Public Meeting; Extension of Comment Period
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is extending the comment period for the notice of public meeting, that appeared in the Federal Register of August 9, 2010 (75 FR 47820). In the notice, FDA requested comments to gather stakeholder input on the development of a generic drug user fee program. The Agency is taking this action to allow interested persons additional time to submit comments.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →